Bayer increases bid for Monsanto

Screen Shot at AM

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

Bayer AG has raised the stakes in its attempt to buy Monsanto Co. and create a chemical and agricultural giant.

Two months after its first offer for the seed and farm products manufacturer was rejected, the German company upped its bid to $54.7 billion in cash, a $3-a-share increase to $125 a share. [July 14th’s] proposal came just hours after news that St. Louis-based Monsanto might entertain a deal with another German chemicals giant, BASF SE.

. . . .

Yet the developments at Bayer, Monsanto and BASF all underscore the brisk consolidation sweeping the chemicals business, as well as Bayer Chief Executive Officer Werner Baumann’s determination to form the world’s largest supplier of crop seeds and chemicals. . . .

. . . .

One of the key concerns has been that a deal between Monsanto and Bayer, coming amid a wave of megadeals in the agricultural-chemicals and seeds industry, may invite close scrutiny from regulators. . . .

Buying Monsanto would give Bayer a controversial pioneer of genetically modified crops, which while valuable, have also been a lightning rod for environmental activists in Europe and elsewhere.

Read full, original post: Bayer Raises Bid to Lure Monsanto as Investors Still Skeptical

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jul-17-2026-12_42_10-PM
Viewpoint: RFK, Jr. is setting up a panel to compensate people who claim they were injured by a COVID vaccine–no proof needed 
ChatGPT-Image-Jul-6-2026-02_25_26-PM
40 million Americans take glucosamine. If you have memory loss, it could accelerate cognitive decline.
Screenshot-2026-07-17-at-12.55.22-PM
Viewpoint: Is bagged salad a dangerous science experiment? Challenging an online misinformation campaign
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
px-Minced-beef-meat-cow-cattle
Can we trust Trump’s USDA to accurately report farm data? Beef export numbers suggest ‘no’.
ma art page image
‘It’s time to have a conversation’: Once adamantly opposed to human gene editing, UK’s The Guardian acknowledges likely benefits
ChatGPT-Image-Jun-17-2026-03_29_08-PM
Viewpoint: What’s the impact of the U.S. abandoning support for global health?
Screenshot 2026-07-11 094410
Growing animal muscle and fat cells inside rice grains and calling it beef: One of numerous genetically engineered products shaking up our ecosystem
afb-a-b
As the EU loosens restrictions on agricultural gene editing, it remains years behind the rest of the world on equally-safe GMO foods
file-f-d-d-
Facts & Fallacies Podcast: Europe's AC debacle underscores fatal flaw in green activism
ChatGPT-Image-Jul-8-2026-12_32_48-PM
Viewpoint: SCOTUS strikes a blow against junk science in Bayer glyphosate case. Will it deter mass tort litigators?
ChatGPT-Image-Jul-9-2026-02_39_22-PM
Viewpoint: Polyphenols or NAD+ supplements to combat aging: No, Gwenyth Paltrow and followers, don’t waste your money.
Screenshot-2026-07-16-at-11.32.12-AM
Viewpoint: Trump appoints climate change hoax promoter to head influential government policy project
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.